Neutrophilic lobular panniculitis associated with rheumatoid arthritis
To our knowledge, there are only 4 reported cases of this unusual variant of panniculitis. It consists of a neutrophilic lobular panniculitis with vasculitis in patients with rheumatoid arthritis. This variant of panniculitis has been named pustular panniculitis, [7] [8] [9] [10] which in our opinion is an inaccurate term because the lesions are not pustules but erythematous subcutaneous nodules. Neutrophilic lobular panniculitis with vasculitis is an uncommon variant of panniculitis in patients with rheumatoid arthritis because these patients present classic erythema nodosum as the most frequent form of panniculitis. Clinically, the 4 described patients with this uncommon variant of panniculitis were middle-aged women with long-standing rheumatoid arthritis. The exhibit a necrotizing vasculitis of the small vessels in the upper and mid dermis that results in ulceration of the epidermis. 5 In addition to the vasculitis, there is a mild perivascular inflammatory infiltrate composed mostly of foamy histiocytes that contain numerous acid-fast bacilli. 6 Bacilli may also be demonstrated within the endothelial cells. Occasionally, the process extends deep into the subcutaneous fat, with smallvessel vasculitis in the fat lobules. Usually, cutaneous lesions of Lucio's phenomenon show an inflammatory infiltrate of lesser intensity than those of erythema nodosum leprosum. 6 Thalidomide is also used in the treatment of Lucio's phenomenon, 3 although the severe recurrent ulceration due to deep subcutaneous vasculitis is often accompanied by systemic vasculitis, and this type of leprosy reaction may be fatal. cutaneous lesions appeared suddenly in the form of painful subcutaneous erythematous nodules on the posterior aspect of the lower legs. [7] [8] [9] [10] In some of the patients, ulceration with discharge of liquefied fat occurred. Histopathologic examination of the lesions showed a mostly lobular panniculitis, with severe necrosis of the adipocytes in the fat lobule and an inflammatory infiltrate composed of neutrophils, foamy histiocytes, and multinucleated giant cells. Small cystic spaces lined by amorphous eosinophilic material were seen in some cases as an early expression of lipomembranous or membranocystic panniculitis. 10 Focally, features suggestive of leukocytoclastic vasculitis such as nuclear dust and neutrophils in perivascular arrangement were seen, although no fibrin deposits in the vessel walls or unquestionable leukocytoclastic vasculitis could be demonstrated. One of these 4 patients with neutrophilic lobular panniculitis and rheumatoid arthritis also had leukocytoclastic vasculitis involving the blood vessels of the papillary dermis. 8 Because only a few patients with this rare variant of panniculitis have been described, it is difficult to evaluate the response to different treatments. In one patient with neutrophilic lobular panniculitis and rheumatoid arthritis, a course of dapsone was initiated, but it was discontinued after 6 weeks because of a drop in the patient's hematocrit. Shortly after the dapsone was discontinued, the nodular eruption on the lower extremities resolved. 10 
Erythema induratum of Bazin (nodular vasculitis)
Currently, the terms erythema induratum of Bazin and nodular vasculitis are used as synonyms by most authors to describe the most common form of lobular panniculitis with vasculitis. However, this has not always been the case. This form of panniculitis was described by Bazin 11 in 1861, as subcutaneous indurated erythematous plaques appearing mainly on the posterior aspects of the lower legs of middle-aged women. He classified the process as one of the "erythematous benign scrofulids," which also included rosacea and chilblains. Bazin used the term "scrofulids" as a descriptive term to refer to deep erythematous nodules, and it seems that he did not consider this panniculitis as a tuberculid. The link between tuberculosis and erythema induratum was emphasized later, around 1900, mostly by French dermatologists who included erythema induratum within the spectrum of the tuberculids. 12 Almost simultaneously, identical clinical cases with no evidence of tuberculosis were reported by English authors, 13, 14 which led later to the development of Whitfield's concept of erythema induratum as nontuberculous in origin. 15 In 1945, Montgomery, O'Leary, and Barker 16 in the United States proposed the term nodular vasculitis for Whitfield's erythema induratum and described its clinical and histopathologic features as different from those of erythema induratum of Bazin. Since then, most popular textbooks of dermatology describe erythema induratum of Bazin, erythema induratum of Whitfield, and nodular vasculitis as 3 different entities. 17 Still some current authors have proposed to keep the name erythema induratum of Bazin for those cases in which an etiologic relationship with tuberculosis is demonstrated and refer to the remainder of cases as nodular vasculitis. In recent years there seems to be a consensus considering erythema induratum of Bazin and nodular vasculitis as the same entity, 18, 19 an opinion that we share. Like erythema nodosum, erythema induratum of Bazin (nodular vasculitis) is currently considered to be a reactive disorder related to several etiologic factors, one of which may be tuberculosis, especially in some geographic areas. 20 In our country, tuberculosis is by far the most important etiologic factor for erythema induratum of Bazin (nodular vasculitis), and recent polymerase chain reaction investigations have demonstrated Mycobacterium tuberculosis DNA in 77% of the cutaneous biopsy specimens of patients with this variant of panniculitis. 21 Although the frequency varies from some geographic areas to others, in many countries tuberculosis is still the main etiologic factor for erythema induratum of Bazin (nodular vasculitis). [22] [23] [24] [25] [26] [27] [28] [29] Typical erythema induratum of Bazin (nodular vasculitis) is a disease of middle-aged women in whom erythematous subcutaneous nodules and plaques appear on the posterior aspects of the lower legs (Fig 1) . Erythrocyanosis, heavy column-like calves, erythema surrounding follicular pores, and cutis marmorata are frequently associated changes and may be predisposing factors. Although nonulcerated lesions may heal without scarring, often subcutaneous nodules become adherent to the skin surface and ulcerate. Healing of these ulcers is usually a slow process, resulting in atrophic scars that allow retrospective diagnosis in old residual cases. Erythema induratum of Bazin is more frequent in obese women with some degree of venous insufficiency of the lower extremities, and subcutaneous nodules with ulceration develop mostly during cold winter months. Lesions are usually tender but may be indolent or painful only on pressure. The course is protracted and recurrent episodes over years, even decades, are common. Individual lesions tend to involute, but new crops appear at irregular intervals. Patients with erythema induratum of Bazin (nodular vasculitis) are otherwise in good health.
Atypical forms of erythema induratum of Bazin (nodular vasculitis) are seen in men, with unilateral lesions, involving shins, thighs, or elsewhere.
From a histopathologic point of view, erythema induratum of Bazin (nodular vasculitis) is mostly a lobular panniculitis (Fig 2) . At an early stage, the fat lobules are punctuated throughout by discrete collections of inflammatory cells, mostly neutrophils. There may be extensive necrosis of the adipocytes of the fat lobule. These necrotic adipocytes call for histiocytes that ingest lipid and become foamy. Epithelioid histiocytes, multinucleated giant cells, and lymphocytes contribute to the granulomatous appearance of the inflammatory infiltrate in fully developed lesions of erythema induratum of Bazin (nodular vasculitis). When intense vascular damage is present, extensive areas of caseous necrosis appear and the lesions show all the histopathologic attributes of tuberculosis. Caseous necrosis may extend to the overlying dermis and secondarily involve the epidermis with ulceration and discharge of liquefied necrotic fat.
Controversy persists in the literature about whether or not vasculitis is a histopathologic requirement to establish the diagnosis of erythema induratum of Bazin (nodular vasculitis). Even with vasculitis 
A B
accepted as a histopathologic criterion, there is no agreement about the nature of the involved vessel. Some investigators believe that the involved vessel in erythema induratum of Bazin (nodular vasculitis) is an artery, 30, 31 whereas other authors favor a venous involvement, 32 and still others consider that both arteries and veins are involved. 16, [33] [34] [35] [36] [37] In our experience, veins and venules are the primary affected vessels, whereas arteries are secondarily entrapped within large areas of caseous necrosis of the fat lobule. 38 In a recent series of patients with erythema induratum of Bazin (nodular vasculitis), the lesions were histopathologically classified into two types: focal panniculitis (type I) and diffuse panniculitis (type II).
In type I erythema induratum of Bazin (nodular vasculitis) only one artery or a small blood vessel within the fat lobule was involved by neutrophilic vasculitis.
In type II erythema induratum of Bazin (nodular vasculitis) several blood vessels of different sizes both in the septa and the fat lobule showed features of neutrophilic vasculitis. Necrosis of the adipocytes and inflammatory response were more intense in type II. 39 In our opinion, this classification is difficult to apply in a particular case and does not have any practical use. In our experience, some cases with all the stereotypical clinicopathologic features of erythema induratum of Bazin (nodular vasculitis), serial sections through the block of a subcutaneous nodule do not demonstrate findings of vasculitis. Therefore we do not consider vasculitis as a sine qua non criterion to establish the diagnosis of erythema induratum of Bazin (nodular vasculitis) when other characteristic findings are present. In those cases in which there is a strong positive reaction in the Mantoux test 40 or Mycobacterium tuberculosis DNA is demonstrated in the cutaneous biopsy specimen by polymerase chain reaction techniques, a full course of 9 months of antituberculosis triple-agent therapy is recommended. [40] [41] [42] [43] [44] [45] [46] [47] As with erythema nodosum, potassium iodide has been reported as effective and rapid treatment for erythema induratum of Bazin (nodular vasculitis). 48, 49 Supporting bandages, bed rest, and treatment of the venous insufficiency of the lower extremities are also helpful. Nonsteroidal anti-inflammatory drugs may be used to alleviate painful ulcers.
Crohn's disease
Crohn's disease involving the skin is usually characterized by abscesses, sinuses, and fistulas on the genital and perianal areas. These lesions are histopathologically characterized by noncaseating granulomas composed of epithelioid histiocytes and involving the full thickness of the dermis with a morphology very similar to that of the bowel disease. 50, 51 When lesions of Crohn's disease involve the lower extremities, they show a clinical appearance similar to erythema nodosum, but histopathologically they consist of noncaseating granulomas involving the septa of subcutaneous fat. 52 However, cases of authentic erythema nodosum, with Miescher's radial granulomas in the septa, have also been described in patients with Crohn's disease. In these cases the subcutaneous nodules are usually related to the activity of the bowel disease and regress when the bowel improves. 53, 54 There are also reports of cutaneous polyarteritis nodosa in patients with Crohn's disease. [55] [56] [57] [58] [59] [60] [61] However, the panniculitis included in this section is different from those previously mentioned. In some instances, patients with Crohn's disease present with a mostly lobular panniculitis characterized by noncaseating granulomas within the fat lobules and lymphocytic vasculitis involving the walls of medium-sized vessels at the junction of the dermis and the subcutaneous fat. This variant of lobular panniculitis is described, though not illustrated, in the second edition of the textbook Histologic Diagnosis of Inflammatory Skin Diseases by Ackerman et al. 62 We have been unable to find other references to this type of lobular panniculitis in Crohn's disease; therefore it seems to be very rare.
MOSTLY LOBULAR PANNICULITIS WITHOUT VASCULITIS

Sclerosing panniculitis
Jorizzo et al, 63 in 1991, proposed the term sclerosing panniculitis as the best name to describe a variant of panniculitis previously known by a variety of names, including hypodermitis sclerodermiformis, 64 lipodermatosclerosis, 65 and lipomembranous change in chronic panniculitis. 66 The cutaneous lesions of this disorder consist of woodlike indurated plaques with erythema, edema, telangiectasia, and hyperpigmentation involving the lower legs with a stocking distribution. The condition is usually associated with chronic venous insufficiency, arterial ischemia, and previous episodes of thrombophlebitis. The involved area of the lower extremities resembles an inverted bottle, a deformity secondary to extensive deep fibrosis and sclerosis resulting in atrophy of the subcutaneous fat (Fig 3) . In the original description, this process was thought to be an infectious disease related to unusual acid-fast bacteria, 64 but subsequent studies failed to identify any bacteria in the cultures of the lesions. Currently, venous insufficiency of the lower extremities is considered to be the main etiologic factor of sclerosing panniculitis. Venous insufficiency leads to sludging in the lobular capillaries, which results in ischemia and necrosis of the central portion of the fat lobule. 63 Histopathologic findings in sclerosing panniculitis vary according to the evolution of the lesions. In any stage, changes of stasis dermatitis are present in the superficial dermis, with a proliferation of capillaries and venules in the papillary dermis, fibrosis, and abundant hemosiderin deposition. In the early stages of sclerosing panniculitis, there is sparse inflammatory infiltrate mostly composed of lymphocytes between the collagen bundles of the septa. There are also areas of ischemic necrosis at the center of the fat lobule, manifested as pale, small, anucleated adipocytes. Small lobular vessels appear congested and sometimes there are numerous extravasated erythrocytes, hemosiderin, and necrosis of endothelial cells within the areas of fat necrosis. In later stage lesions, the septa appear thickened and fibrotic, resulting in dramatic atrophy of the subcutaneous fat. The inflammatory infiltrate is composed of lymphocytes, histiocytes, and foamy macrophages. The periphery of the fat lobule often shows lipophagic granuloma with scattered lymphocytes and plasma cells. In late-stage lesions, septal sclerosis is the main histopathologic finding. The fat lobules become small because of lypophagic fat necrosis and there are fatty microcysts with foci of membranocystic changes (Fig 4) . These consist of amorphous eosinophilic or amphophilic 
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material, sometimes with corrugated appearance, lining cystic spaces that result from fat necrosis. 66 Lipomembranous or membranocystic fat necrosis is a frequent finding in late-stage lesions of sclerosing panniculitis but is not exclusive to any type of panniculitis. It has been described in long-standing lesions of many variants of lobular panniculitis. 66 Treatment of sclerosing panniculitis is difficult. In some cases, standard measurements for venous insufficiency of the lower extremities, including compression stockings, have been useful but not curative. Some authors have reported that the anabolic steroid stanozolol improves this condition rapidly and consistently. 65 
Calciphylaxis
Calciphylaxis is an uncommon and poorly understood cutaneous process usually associated with chronic renal failure. Its main feature is the calcification of cutaneous vessel walls resulting in necrosis and ulceration. In 1962, Selye 67 described calciphylaxis from a pathogenic point of view as a purely experimental phenomenon observed in an animal model system. He postulated that two steps are required in calciphylaxis: (1) a systemic "sensitization" with one or several agents, such as parathyroid hormone, vitamin D, or a diet with high calcium and phosphorus contents. Nephrotoxic agents would increase the potential of these sensitizer agents. 68 (2) After a "critical period," there is exposure to the appropriate "challenging" agents, such us local trauma, iron salt and various other inorganic metal salts, glucocorticoids, albumin, egg white and yolk, polymixin, 5-hydroxytryptamine and other mast cell releasers, and radiopaque contrast media. 69, 70 In humans, calciphylaxis occurs almost exclusively in patients with end-stage chronic renal failure, although rarely patients with normal renal function have been reported. 71 Most of these patients have abnormalities in calcium-phosphorus metabolism, with elevated serum calcium and phosphorus levels, often in the context of the secondary hyperparathyroidism associated with renal failure. However, these tests are normal in some patients with calciphylaxis, supporting the idea that other factors are also involved in the pathogenesis of calciphylaxis. It seems that arterial hypertension and posthemodialysis metabolic alkalosis also predispose patients to calciphylaxis. Vascular calcification of calciphylaxis often persists despite the decrease of the calcium-phosphate products, 72 in contrast to the benign nodular calcification, that appears in patients with chronic renal failure and abnormalities of the calcium-phosphorus metabolism and disappears with normalization of serum calcium and phosphate levels. 73 Functional abnormalities in either protein C or protein S have been reported in several patients with calciphylaxis, which supports the idea that a preexisting hypercoagulable stage predisposes affected patients to calciphylaxis. 74 However, these proteins are normal in other patients. 67, 71 Calciphylaxis has been also described in AIDS patients with renal failure. 75 From a clinical point of view, cutaneous lesions of calciphylaxis usually appear in patients with endstage renal disease undergoing hemodialysis or after kidney transplantation. Skin lesions consist of violaceous, mottled to reticulated patches and plaques resembling livedo reticularis (Fig 5) . Occasionally bullae have been reported. Lesions evolve to necrotic, indurated plaques and nodules, resulting in large, deep, nonhealing ulcers associated with significant tenderness, ischemic digital pain, and, in some cases, gangrene of the digits, which necessitates amputation. The lesions exhibit bilateral symmetry, and distal parts of the extremities, thighs, and buttocks are the most frequently involved sites. 72, 73, [76] [77] [78] [79] [80] [81] Less frequently the trunk and upper extremities are affected by cutaneous lesions of calciphylaxis. Necrosis of the penis secondary to calciphylaxis has also been descibed, 69, 82 and we have recently seen an example of this. 83 Despite dramatic ulcers and necrosis, no internal organ failure is usually reported in patients with calciphylaxis.
Histopathologic features in cutaneous lesions of calciphylaxis are characteristic. They consist of calcium depositions in the walls of small-to mediumsized-diameter blood vessels of the reticular dermis and subcutaneous fat (Fig 6) . These are associated with lobular fat necrosis, intralobular calcification, and inflammatory infiltrate of neutrophils, lymphocytes, and foamy histiocytes. [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] This histopathologic picture of ischemic necrosis, with infarction of the adipocytes within the lobule and congested capillaries, closely resembles the early changes seen in sclerosing panniculitis. In calciphylaxis, however, the calcification of the vessel walls and subsequent endovascular fibrosis is the cause of ischemia. Some patients with calciphylaxis, in addition to vascular calcification in the deeper dermis and subcutaneous fat, also show calcium deposition in the lower dermis and subcutaneous septa that appears to involve elastic tissue, similar to pseudoxanthoma elasticum. 84 The prognosis in patients with calciphylaxis is poor, and a review of the literature reveals the mortality rate to be as high as 80%. 68 In some patients, parathyroidectomy with normalization of abnormal calcium and phosphorus serum levels stopped the progression of the disease. 68 In patients with chronic renal failure undergoing hemodialysis, a diet poor in calcium and phosphorus, binding agents, and low-phylaxis die of overwhelming infection and sepsis resulting from a compromised skin barrier in an immunosuppressed patient with chronic renal failure or after kidney transplantation.
Oxalosis
Oxalosis is another rare crystalline deposit-associated panniculitis seen in relationship with renal failure. There are two forms of oxalosis, namely, primary or inherited oxalosis and secondary or acquired oxalosis. Primary oxalosis is an autosomal recessive inherited metabolic disease caused by enzymatic defects. 89 Primary oxalosis includes two different metabolic diseases, both with similar clinical manifestations, but with different basic enzymatic defects: type I primary oxalosis results from a deficiency of 2-hydroxy-3-oxoadipate carboxylase, whereas type II primary oxalosis is a deficiency of D-glyceric dehydrogenase. 89 Secondary oxalosis results from excessive oxalate or glycolic acid ingestion, ethylene glycol poisoning, intravenous glycerol or xylitol infusion, methoxyflurane anesthesia, pyridoxine deficiency, intestinal disease, ileal resection, and, in the setting of chronic renal failure, in hemodialysis. 90, 91 Both primary and secondary oxalosis often lead to renal failure and death of the patient.
Cutaneous involvement is more frequent in secondary than in primary oxalosis. In secondary oxalosis the presence of miliary deposits of calcium oxalate on the palmar aspects of the fingers is characteristic. 90, 92 This calcium deposition in the dermis calls for histiocytes and granulomatous inflammation appears in the dermis surrounding the crystals. In contrast, cutaneous lesions in primary oxalosis, when present, calcium hemodialysis is recommended. 86 In single case reports, improvement of cutaneous lesions of calciphylaxis has been reported after hyperbaric oxygen therapy 87 and with prednisone and subsequent cimetidine. 88 Unfortunately, most patients with calci- 
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consist of livedo reticularis and acral gangrene. 89, [93] [94] [95] [96] [97] Biopsy findings of skin lesions of primary oxalosis show calcium deposition and oxalate crystals on the vessel walls, with a histopathologic picture quite similar to that of calciphylaxis. 89, [93] [94] [95] [96] [97] [98] Often the involved blood vessels show luminal thrombosis. Treatment is different in primary and secondary oxalosis. In secondary oxalosis kidney transplantation is usually followed by significant improvement of the disease, but in primary oxalosis renal graft survival is limited because of recurrent oxalate deposition. If diagnosis is established before the onset of renal failure, treatment consists of large volume of fluid, alkalinization, and medications to minimize the oxalate formation, trying to maintain renal function as long as possible. When renal failure is established, kidney transplantation should be combined with hepatic transplantation to revert the underlying enzymatic deficiency. 99 
Sclerema neonatorum
Sclerema neonatorum is rare because of the improvements in neonatal care. Most of the cases of this rare disorder have been described in low-weight premature newborns during the course of a wide variety of severe illnesses, particularly serious infections, congenital heart disease, and other major developmental defects. The affected infant is generally severely ill at the onset of sclerema neonatorum, and cutaneous lesions appear during the first days of life. These usually begin on the buttocks and thighs in the form of diffuse yellow-white woody induration of the skin and rapidly extend to involve large areas of the body, resulting in immobility of the extremities. The prognosis is poor and most infants affected with sclerema neonatorum die within a few days. 100 It has been postulated that the ratio of saturated to unsaturated fatty acids is relatively high in the adipose tissue of all neonates and that this ratio is even higher in infants with sclerema neonatorum, thereby predisposing premature and small-for-gestational age infants to this disease. 101 From a histopathologic point of view, at first glance the cutaneous biopsy specimen shows little abnormality in the subcutaneous fat. Inflammatory infiltrate is sparse or even absent, and the process does not resemble a panniculitis. The sparse inflammatory infiltrate reflects the poor immunologic response of the severely ill infant. There is little evidence of fat necrosis, but the most characteristic feature of sclerema neonatorum is the presence of radially arranged, needle-shaped clefts in adipocytes, and, occasionally, in some of the few multinucleated giant cells present in the sparse inflammatory infiltrate. 102 Autopsy studies in infants who died as a consequence of sclerema neonatorum have identified identical needleshaped crystals in adipocytes of visceral fat. 103, 104 Treatment of sclerema neonatorum is primarily treatment of the underlying disease. Systemic corticosteroids are ineffective, but there is evidence that repeated exchange transfusions may reduce mortality. 105 Infants who survive an episode of sclerema neonatorum during the first week of life have normal-appearing skin with no calcifications or other long-term complications.
Cold panniculitis
Cold panniculitis is also more frequent in infants after exposure to severe cold. [106] [107] [108] Cases of this variant of panniculitis have also been described in the cheeks of children sucking ice cubes, ice packs, or ice lollies (popsicles). 109, 110 Cold panniculitis may also develop during cold months in the thighs or buttocks of women who ride horses wearing tight trousers that obstruct the blood supply to the subcutaneous fat (equestrian panniculitis). 111, 112 Clinically, the affected areas appear as indurated erythematous plaques with ill-defined margins. If the involved area is kept warm, the plaques slowly soften and resolve in some days without scarring.
Biopsy specimens of cold panniculitis show a mostly lobular panniculitis with an inflammatory infiltrate of lymphocytes and histiocytes in the fat lobules. There may also be marked edema in the papillary dermis as well as superficial and deep perivascular lymphocytic infiltrate in the dermis that extends to the subcutaneous septa. The histopathologic findings closely resemble those of perniosis. 113 Cold panniculitis resolves if further exposure to cold is avoided. In horse-riding women with inadequate clothing, looser trousers should be recommended. Vasodilator drugs are not effective in preventing or treating cold panniculitis.
Lupus panniculitis (lupus erythematosus profundus)
Lupus panniculitis is a chronic recurrent panniculitis that appears in approximately 1% to 3% of patients with cutaneous lupus erythematosus. 114, 115 Lupus panniculitis is more frequent in women than in men, and the lesions have a predilection for the upper arms, shoulders, face, and buttocks, which are areas infrequently involved by other variants of panniculitis. Cases of lupus panniculitis involving the subcutaneous fat of the breast ("lupus mastitis"), [116] [117] [118] orbital, 119, 120 and periparotid fat tissue 121, 122 have also been recorded. Unusual forms of lupus panniculitis include lesions mimicking morphea, 123 linear arrangement of the lesions, 124 and the association of Histopathologic findings in lupus panniculitis are relatively characteristic. In more than half of the cases, there are epidermal and dermal changes of discoid lupus erythematosus. These include atrophy of the epidermis, vacuolar change at the dermoepidermal junction, thickened basement membrane, interstitial mucin between collagen bundles of the dermis, and superficial and deep perivascular inflammatory infiltrate of lymphocytes involving the dermis. 128, 129 In the other half of the cases, the changes are confined to the subcutaneous fat, with no anomalies in the dermis or epidermis. There is a mostly lobular panniculitis with inflammatory infiltrate predominantly composed of lymphocytes (Fig 8) . A characteristic feature, found in more than half of the patients, is the presence of lymphoid follicles. 130 Often, these lymphoid follicles show germinal centers and numerous plasma cells at the periphery that also extend interstitially between collagen bundles of the septa of the subcutis. Lymphoid follicles in the subcutaneous fat are quite characteristic of lupus panniculitis, but they are not exclusive because they have also been described in deep morphea, erythema nodosum, panniculitis associated with dermatomyositis, and erythema induratum of Bazin. 131 Necrosis of adipocytes is usually sparse or absent in lupus panniculitis. Sometimes, however, lymphocytes of the infiltrate show nuclear dust, an infrequent finding in other variants of lobular panniculitis, so that it has been proposed as a clue to the diagnosis of lupus panniculitis. 132 Collagen bundles of subcutaneous septa appear to be hyaline and sclerotic, and they also contain an interstitial inflammatory infiltrate of lymphocytes and plasma cells. Less constant features that have been described in cases of lupus panniculitis include lymphocytic vasculitis in the small blood vessels of the fat lobule, hyaline necrosis of the vessel walls, abundant mucin between collagen bundles, calcification, and numerous eosinophils in the inflammatory infiltrate. 133 As in other variants of lobular panniculitis, late-stage lesions of lupus panniculitis may show membranocystic changes. 134, 135 Immunofluorescence studies in lesions of lupus panniculitis have in most cases shown a linear deposition of IgM and C3 along the dermoepidermal junction. 115, 128 Immunofluorescent deposits in the subcutaneous fat are more inconstant and difficult to accomplish technically. When a biopsy specimen of clinically typical lesions of lupus panniculitis does not show definitive findings, the positive lupus band test along the dermoepidermal junction supports a diagnosis of lupus panniculitis. 127 Local treatment with potent corticosteroids under occlusion has been reported as being helpful lupus panniculitis and neonatal lupus erythematosus. 125 Occasionally, subcutaneous nodules of lupus panniculitis are the only clinical manifestation of lupus erythematosus. 126 Trauma to subcutaneous fat seems to be a precipitating factor for lesions of lupus panniculitis. Some patients develop the lesions at the point of previous injections, and the aggravation of the process at the site in which a biopsy is taken or recurrence of the subcutaneous nodules along scars of previous excisions are distinctive clinical features of lupus panniculitis. 127, 128 Clinically, the lesions consist of deep situated subcutaneous nodules or plaques. The surface of the nodules may show classic features of discoid lupus erythematosus 125 or may appear as normal skin. When lesions of lupus panniculitis regress, they leave atrophy and swelling of the involved area. Persistent areas of lipoatrophy on the shoulders and upper arms are so characteristic that they allow a retrospective diagnosis of lupus panniculitis (Fig 7) . Subcutaneous nodules of lupus panniculitis may precede, appear simultaneously, or develop after other extracutaneous manifestations of systemic lupus erythematosus, 129 but usually patients with lupus panniculitis have a mild disease course. in lesions of lupus panniculitis, 136 but often a systemic course of corticosteroids 116 or hydroxychloroquine 137 is necessary. Dapsone has also been reported as effective in the management of lupus panniculitis. 138 
Panniculitis in dermatomyositis
Panniculitis is less frequent in dermatomyositis than in lupus erythematosus and scleroderma. In a series of 55 patients with dermatomyositis and cutaneous lesions, studied histopathologically, panniculitis was only demonstrated in 5 cases. 139 In some patients, lesions of panniculitis are present in association with other characteristic cutaneous lesions of dermatomyositis, 140 whereas in other cases panniculitis is the only cutaneous manifestation of the disease. 141 Histopathologic findings in lesions of panniculitis associated with dermatomyositis are quite similar to those of lupus panniculitis. There is a mostly lobular panniculitis with lymphocytes and plasma cells among the adipocytes. The collagen bundles of the septa show hyaline sclerosis, and there is progressive replacement of fat with fibrous tissue. 127 Additional histopathologic findings in lesions of panniculitis associated with dermatomyositis include thickening of the blood vessels of the fat lobule, neutrophilic vasculitis with fibrinoid necrosis or lymphocytic vasculitis involving the arterioles of the septa, and calci- In some patients, however, there is no demonstrable pancreatic disease, although high serum levels of pancreatic lipase of unknown origin were detected. 174 Recently a case of pancreatic panniculitis has been reported in association with primary HIV infection and a hemophagocytic syndrome. 175 Clinically, cutaneous lesions of pancreatic panniculitis appear as erythematous subcutaneous nodules that spontaneously ulcerate and exude an oily brown material, which results from liquefaction necrosis of adipocytes (Fig 9) . The distal parts of the lower extremities, around the ankles and knees, are the most frequent locations of these lesions, 174 although nodules of pancreatic fat necrosis have also been described in other areas including the thighs, buttocks, calves, arms, and abdominal skin. Cases of pancreatic panniculitis with a single subcutaneous nodule have been reported. 176 Usually, those cases associated with pancreatitis show resolution of the cutaneous lesions when the inflammatory episode of the pancreas regresses. In contrast, subcutaneous nodules of pancreatic panniculitis in patients with pancreatic carcinoma tend to be more chronic and persistent, with frequent recurrences, ulceration, and involvement of cutaneous areas beyond the lower extremities. 177 Often the onset of subcutaneous fat necrosis in pancreatic diseases is accompanied by acute arthritis that results from necrosis in periarticular fat tissue. 151, 154, [177] [178] [179] [180] [181] [182] In rare instances pancreatic panniculitis is associated with necrosis of the abdominal fat, 178 bone marrow fat, 163 pleural effusions, 158, 166 mesenteric thrombosis, 166 and leukemoid reaction and eosinophilia. 174 A patient with pancreatic panniculitis and pancreatic carcinoma developed a woodlike induration of the fingers as a consequence of an associated fasciitis. 183 From a pathogenic point of view, it has been proposed that pancreatic enzymes, mostly lipase, that escape to the blood from the inflamed pancreas are responsible for the subcutaneous fat necrosis in enzymatic panniculitis. 156, 174 The finding of pancreatic lipase in the areas of subcutaneous necrosis, 174 and the immunohistochemical demonstration with anti-lipase monoclonal antibodies of that enzyme within the necrotic adipocytes 155 support the pathogenic role of pancreatic lipase. However, pancreatic lipase must not be the only etiologic factor because there is a contrast between the relative frequency of pancreatitis with high serum levels of lipase and the fact that pancreatic panniculitis is a rare disorder. 184 Furthermore, in vitro investigations failed to reproduce pancreatic panniculitis when normal human subcutaneous fat was incubated with the serum of a patient with high levels of pancreatic lipase, trypsin, and amylase. 156 Well-docufication. Lymphoid follicles, with or without germinal center formation, have also been described in lesions of panniculitis in dermatomyositis, 142 but this finding is less frequent than in lesions of lupus panniculitis or deep morphea. As in lupus panniculitis, some lesions of panniculitis associated with dermatomyositis exhibit vacuolar change at the dermoepidermal junction. [141] [142] [143] Late-stage lesions may also show membranocystic change. 144 Immunofluorescence studies have only been performed in 3 cases of panniculitis associated with dermatomyositis. The results were negative in one case. 142 Another case had deposits of IgM, C3, and fibrinogen in the blood vessel walls of the dermis, but not at the dermoepidermal junction. 141 The third case showed deposits of C3 at the basement membrane zone of the dermoepidermal junction and around the dermal blood vessels, but in the subcutaneous fat only deposits of fibrinogen were detected. 142 In general, patients with dermatomyositis and associated panniculitis seem to be a subgroup of patients with a good prognosis, with no higher incidence of malignancy, as is the case in other patients with dermatomyositis. 145 Only one patient with dermatomyositis and panniculitis had an associated rhabdomyosarcoma. 146 More common than pure panniculitis in dermatomyositis is the panniculitis associated with calcification of the muscle and deep tissue. In these cases the fat lobules show lipophagic granuloma, calcification, and various degrees of acute and chronic inflammation. 127 Lesions of panniculitis in patients with dermatomyositis respond to systemic treatment of dermatomyositis and the best response is with high-dose courses of corticosteroids. 140, 142 
Pancreatic panniculitis
Several pancreatic diseases have been associated with a characteristic variant of panniculitis, named pancreatic or enzymatic panniculitis. This variant appears in approximately 2% to 3% of all patients with pancreatic diseases. 147 It has mostly been described in association with acute and chronic pancreatitis, [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] but also in patients with pancreatic carcinoma, more frequently with acinar cell carcinoma type, [158] [159] [160] [161] [162] and less commonly with pancreatic islet cell carcinoma. [163] [164] [165] In some patients with pancreatic panniculitis the skin lesions were the presenting feature of the pancreatic disease. 158, 166 Other less frequent pancreatic abnormalities that have been described in association with pancreatic panniculitis include pancreas divisum, 167, 168 pancreatic pseudocysts, [169] [170] [171] vasculopancreatic fistulas, 172 and pancreatitis secondary to sulindac intake. 173 These cases are interpreted to be mented examples of pancreatic panniculitis have been described in patients with normal serum levels of all pancreatic enzymes. 185, 186 From a histopathologic point of view, pancreatic panniculitis shows the characteristic features of a mostly lobular panniculitis with intense necrosis of the adipocytes. 187 Some authors have proposed that the earliest feature is a septal panniculitis that results from the enzymatic damage of the endothelial cells lining the blood vessels of the septa. These altered endothelial cells allow the crossing of pancreatic enzymes from the blood to fat lobules, resulting in necrosis of the adipocytes. 188 Regardless of the earliest features, fully developed lesions of pancreatic panniculitis show a characteristic coagulative necrosis of the adipocytes, which leads to ghost adipocytes. Ghost adipocytes are those that have lost their nuclei and show a finely granular and basophilic material within their cytoplasm because of calcification (Fig 10) . Often, ghost adipocytes appear grouped in small clusters at the center of the fat lobule, whereas an inflammatory infiltrate of neutrophils is present at the periphery. Dystrophic calcification in ghost adipocytes results from hydrolytic action of pancreatic enzymes on fat followed by calcium deposition, a process known as saponification. In older lesions, fat necrosis and calcified ghost adipocytes are less evident and the fat lobule is replaced by granulomatous inflammatory infiltrate composed of foamy histiocytes and multinucleated giant cells.
Treatment of pancreatic panniculitis is primarily directed to the underlying pancreatic disease. Sometimes, complete resolution of the symptoms occurs when the pancreatic anomaly is surgically corrected. 152, 167 α 1 -Antitrypsin-deficiency panniculitis Clinical manifestations of α 1 -antitrypsin deficiency (α 1 -protease inhibitor deficiency) only appear in homozygous patients. Currently, more than 33 allelic variants of this disorder are known. In every person, two of these alleles combine to determine the pheno-
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the reticular dermis (Fig 12) . Another histopathologic feature considered to be characteristic of α 1 -antitrypsin deficiency is the focality of the lesions, appearing as large areas of normal fat adjacent to necrotic adipocytes containing many neutrophils and histiocytes. 211 Occasionally, the intense inflammatory infiltrate of neutrophils causes collagenolysis and degeneration of elastic tissue with destruction of the septa of the subcutis and then necrotic fat lobules appear to be "floating" and surrounded by neutrophils. 212 Vasculitis, except for that resulting from areas of necrosis, is usually not seen in biopsy specimens from patients with α 1 -antitrypsin deficiency panniculitis. In late-stage lesions, neutrophils and necrotic adipocytes are less evident, and the fat lobules appear to be occupied by lymphocytes, foamy histiocytes, and variable degrees of fibrosis. 210, 214 Trauma and surgical debridements are frequent precipitating factors of panniculitis in patients with α 1 -antitrypsin deficiency and they should be avoided, if possible. Dapsone has proved to be an effective treatment in cases of panniculitis due to α 1 -antitrypsin deficiency. 210, 215, 223, 224 In homozygous patients with severe forms of the disease, presenting with severe emphysema and liver failure, the only therapeutic possibility is supplemental infusion of exogenous α 1 -protease inhibitor concentrate, in an intravenous dose of 60 mg/kg per week, or liver transplantation. 225, 226 At present, the production of α 1 -antitrypsin by genetic engineering is being investigated. 227, 228 
Infective panniculitis
Several bacteria or fungi may cause lobular panniculitis as the main clinical manifestation. These infective panniculitides include infections of the subcutaneous fat caused by Streptococcus pyogenes, 229 Staphylococcus aureus, 229 Pseudomonas spp, 229, 230 Klebsiella, 229 Nocardia spp, 229 atypical mycobacteria, [231] [232] [233] [234] Mycobacterium tuberculosis, 235 Candida spp, 229, 236 Fusarium spp, 229 Histoplasma capsulatum, 237, 238 Cryptococcus neoformans, 31 Actinomyces israelii, 31 Sporothrix schenckii, 31 Aspergillus fumigatus 239 (Fig 13) , and chromomycosis. 31 Most of these infective panniculitides occur in immunosuppressed patients.
The evaluation of patients with neutrophilic lobular panniculitis should include cultures of the biopsy specimen. Infective panniculitis caused by atypical mycobacteria show suppurative granulomas within the lobule, which consist of collections of neutrophils surrounded by epithelioid histiocytes. 234 Immunocompromised patients with these cutaneous infections can present with either primary or secondary skin lesions. Primary cutaneous infections arise either from direct physical inoculation or at the type of α 1 -antitrypsin. The most common allele associated with normal levels of α 1 -antitrypsin is M. Some alleles, such as S and Z, are associated with low levels of plasma α 1 -antitrypsin. A heterozygotic person with PiMS or PiMZ phenotype usually shows moderate deficiency of α 1 -antitrypsin, whereas homozygous patients with phenotype PiZZ have severe α 1 -antitrypsin deficiency with serious clinical manifestations, including emphysema, hepatitis, cirrhosis, vasculitis, angioedema, and panniculitis. [189] [190] [191] In these patients, the liver produces the proenzyme of α 1 -antitrypsin, but the proenzyme is not released. α 1 -Antitrypsin is a serine protease inhibitor that mostly inhibits trypsin activity, but is also a potent inhibitor of chemotrypsin, plasmin, thrombin, neutrophilic elastase, pancreatic elastase, serine proteases, collagenase, factor VIII, and kallikrein. 192 Therefore severe α 1 -antitrypsin deficiency is associated with variable clinical manifestations including disorders of blood coagulation and fibrinolysis, anomalies in the phagocytic mechanisms of the immune response, and abnormalities in activation of zymogens and the release of peptide hormones. [193] [194] [195] [196] [197] [198] [199] From a dermatologic point of view, panniculitis is the most important clinical manifestation of α 1 -antitrypsin deficiency. Panniculitis may be the first sign of the disease, although lesions of subcutaneous fat necrosis usually appear when other clinical manifestations of the disorder have already developed. Cutaneous lesions of α 1 -antitrypsin deficiency panniculitis consist of subcutaneous nodules mostly located on the lower extremities, but other areas of the skin, such as the arms, trunk, and face, are often also involved. 189, The earliest lesions resemble cellulitis and show a tendency to ulcerate and exudate oily material that represents necrotic adipocytes. When lesions resolve, they leave atrophic scars (Fig  11) . Occasionally, lesions of α 1 -antitrypsin deficiency panniculitis appear on areas of previous trauma or on scars of previous cryosurgery. 221 The association of α 1 -antitrypsin deficiency panniculitis and Marshall's syndrome has been described and consists of Sweet's syndrome leading to acquired cutis laxa. This association supports the notion that Marshall's syndrome represents part of the clinical spectrum of α 1 -antitrypsin deficiency. 222 α 1 -Antitrypsin deficiency equally affects both sexes, and it may affect children 217 ; however, subcutaneous fat necrosis due to α 1 -antitrypsin deficiency develops most commonly during adult life. 212 Biopsy specimens of cutaneous lesions of α 1 -antitrypsin deficiency panniculitis show severe necrosis of the fat lobules. A histopathologic feature that has been proposed by some authors 219 as a specific clue to early lesions of α 1 -antitrypsin deficiency panniculitis is the splaying of neutrophils between collagen bundles of site of an occlusive dressing of an indwelling catheter. Secondary cutaneous infections develop from either direct extension, to the chest wall in pulmonary infections, or from hematogenous dissemination. As a consequence of the different routes of dissemination, there are several histopathologic differences. In primary cutaneous infections, the epicenter of the inflammation is the superficial dermis, and thrombosed vessels do not contain intravascular organisms. In contrast, in secondary cutaneous infections, the epicenter of inflammation is more deeply seated and involves only the deep reticular dermis and subcutaneous fat. The blood vessels are thrombosed and dilated with masses of organisms expanding their lumens. 239 In other words, infective panniculitis usually results from hematogenous dissemination; the respiratory tract is the most common portal of entry. In immunosuppressed patients, microorganisms are numerous and they may be identified in tissue sections with the routine hematoxylin-eosin stain (Fig 14) or with special stains (eg, Gram, periodic acid-Schiff, Ziehl-Neelsen). Because anti-BCG immunostaining shows cross-reactivity with many bacteria and fungi as well as high sensitivity and minimal background staining, it has been proposed as the best screening tool for detection of bacterial and fungal microorganisms in paraffinembedded skin specimens. 240 In patients with preserved immune response, the microorganisms are
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sparse and often they cannot be identified with special stains; thus the diagnosis must be established by a positive culture of the lesion or serologic studies. Treatment of infective panniculitis requires systemic administration of antibiotics, which should be selected according to susceptibility tests.
Factitial panniculitis
Some patients inject themselves with the most disparate substances within the subcutaneous fat, thereby causing panniculitis. Other times panniculitis results from the subcutaneous implantation of different materials for cosmetic or therapeutic reasons. These selfinflicted or iatrogenic panniculitides include those caused by some drugs injected in the subcutaneous fat such as povidone, 241 meperidine, 242 pentazocine, 243, 244 and vitamin K 1 , 245 or substances used to augment the size of breasts or genitalia or to correct facial wrinkles or other contour abnormalities such as paraffin, [246] [247] [248] [249] [250] [251] silicone, [252] [253] [254] PMMA-microspheres (Artecoll), 255 or polymethylsiloxane (Bioplastique). 255 Psychiatric patients with personality aberrations have been reported with self-inflicted panniculitis due to subcutaneous injections of the most unsuspected substances including acids, alkalis, mustard, milk, microbiologically contaminated material, urine, and feces. 
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Histopathologically, factitial panniculitis usually shows a pattern of a mostly lobular panniculitis, with an inflammatory infiltrate predominantly composed of neutrophils in early lesions and a more granulomatous infiltrate in late-stage lesions. Sometimes polarization of the slide can identify the refractile foreign material causing the panniculitis. However, some histopathologic findings may be helpful in identifying the nature of the foreign material. For example, in cases of povidone panniculitis stained with hematoxylin-eosin, povidone appears as blue-gray foamy deposits within the cytoplasm of large, distended macrophages that replace the fat lobule. 241 Povidone stains intensely with Congo red and chlorazol-fast pink and variably with periodic acid-Schiff. 241 Lesions of panniculitis secondary to subcutaneous injections of pentazocine show marked sclerosis of the dermis and the septa of subcutaneous fat, with necrotic adipocytes, lipophagic granuloma, and thrombi in the lumina of the small blood vessels of the fat lobule. 244 Subcutaneous injections of vitamin K 1 induce sclerosis of the collagen bundles of the subcutaneous septa and an inflammatory infiltrate of lymphocytes and plasma cells closely resembling the histopathologic features of deep morphea. 245 Paraffinoma develops after injections of mineral oil into tissues, resulting in a histopathologic picture that has been named sclerosing lipogranuloma. Sclerosing lipogranuloma consists of multiple "Swiss-cheese-like" pseudocystic spaces replacing the fat lobules (Fig 15) . These are surrounded by fibrosis and an inflammatory infiltrate composed of foamy histiocytes and multinucleated giant cells. 246, 247 Silicone injections used for cosmetic reasons may produce granulomatous reaction in some patients. This is histopathologically characterized by foamy histiocytes containing multiple vacuoles in their cytoplasm and multinucleated giant cells surrounding polygonal translucent angulated foreign bodies, which represent impurities in the silicone. 253 Bioplastique granulomas present with irregularly shaped cystic spaces of varying size containing jagged, translucent, nonbirefringent foreign bodies surrounded by multinucleated giant cells. 255 Artecoll granulomas show numerous round vacuoles nearly identical in size and shape enclosing round and sharply circumscribed, translucent, nonbirefringent foreign bodies surrounded by sclerotic stroma. 255 Patients with self-inflicted factitial panniculitis are mentally disturbed and psychiatric treatment is usually required. A case of factitial panniculitis mimicking pyoderma gangrenosum has been reported as a manifestation of Münchausen syndrome. 256 In
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patients with panniculitis secondary to materials used for breast augmentation or correction of cosmetic defects, the implanted material should be removed.
Subcutaneous sarcoidosis
Sometimes specific lesions of sarcoidosis are seen involving the subcutaneous fat. Clinically the lesions consist of subcutaneous nodules on the lower extremities (Fig 16) with no signs of inflammation on the skin surface. [257] [258] [259] [260] These are different from the lesions of erythema nodosum that frequently appear in patients with sarcoidosis and that are clinically and histopathologically indistinguishable from lesions of erythema nodosum associated with other disorders.
Histopathologically, these specific subcutaneous nodules of sarcoidosis show small noncaseating granulomas involving fat lobules (Fig 17) with few lymphocytes at the periphery ("naked" granulomas). 257 Sometimes calcification develops on these sarcoidal granulomas, 261 and in some cases small areas of necrosis may appear at their center, raising the differential diagnosis with tuberculosis. 262 This variant of panniculitis does not result from a deep extension into the subcutaneous fat from a dermal 
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sarcoidosis, and subcutaneous sarcoidosis is an inflammatory disorder exclusively involving the subcutaneous fat. Sometimes there is also an accompanying superficial and deep perivascular inflammatory infiltrate of lymphocytes in the dermis. Treatment of subcutaneous sarcoidosis is the same as that for sarcoidosis in general, and systemic corticosteroids have been shown to be the most effective therapy.
Traumatic panniculitis
Traumatic panniculitis may result from accidental blunt trauma in several areas of the skin. Traumatic panniculitis is especially frequent in women with large breasts, in which the excessive breast weight favors the trauma of the mammary subcutaneous fat. Clinically, lesions of mammary traumatic panniculitis appear as indurated nodules deeply situated on the breast tissue that are covered by normal skin or, occasionally, the skin surface shows an "orange peel" appearance, raising the differential diagnosis of breast cancer. 263, 264 Lesions of traumatic panniculitis involving the breasts usually resolve, leaving areas of lipoatrophy. Another frequent location for lesions of traumatic panniculitis is the shin, where erythematous tender subcutaneous nodules appear after minor trauma. Traumatic factitial panniculitis has also been described as a self-inflicted panniculitis due to blunt trauma on the forearm and dorsum of the hand (l'oedeme bleu). 265 Less common variants of traumatic panniculitis include lesions in children involving the face, 266 and panniculitis lesions on points of cupping or places where acupuncture techniques have been performed for relief of pain. 267 The process known as lipoatrophia semicircularis may also be considered a variant of traumatic panniculitis. This presents as semicircular bandlike atrophy of the subcutaneous fat that involves half of the circumference of the anterolateral aspects of the thighs of women who repeatedly knock their thighs against a desk or chair because of their working habits. 268 Another lesion that may be considered to be a residual stage of traumatic panniculitis is the socalled nodular-cystic fat necrosis, also named mobile encapsulated lipoma and encapsulated fat necrosis. The process consists of well-demarcated movable nodules that appear in the subcutis of lower limbs, elbows, or hips after trauma. [269] [270] [271] [272] [273] [274] Histopathologically, subcutaneous nodules of traumatic fat necrosis show cystic spaces of variable size and shape within fat lobules, as a consequence of confluent necrosis of the fat cells, surrounded by variable degrees of fibrosis and hemorrhage. At the periphery of the cystic spaces, foamy histiocytes and lymphocytes are usually present. In late-stage lesions hemosiderin may be abundant both extracellularly and within the cytoplasm of the macrophages. Histopathologic features of traumatic panniculitis are often seen in the re-excision specimens of cutaneous and subcutaneous tumors, as a consequence of the trauma caused by the original surgical procedure. 275 The so-called mobile encapsulated lipomas are lesions totally or nearly totally encapsulated by thin, fibrous tissue that contain well-preserved adipocytes with no evidence of inflammatory infiltrate. At the periphery of the lesions, necrotic
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process is named cephalothoracicobrachial lipodystrophy. 314 However, there are forms of partial lipodystrophy sparing the face, 315 326 Sjögren's syndrome, 327 high titers of thyroid autoantibodies, 328 and recurrent infections. 127 From a histopathologic point of view, lipoatrophy is a residual process of several inflammatory conditions involving the subcutaneous fat lobules. In most cases the histopathologic findings are those of lipophagic granuloma surrounding a small fat lobule, with perilobular fibrosis. In those cases of lipoatrophy secondary to subcutaneous injections of corticosteroids, two different histopathologic patterns have been described. 288 Both patterns are characterized by the small size of the lobules and by the atrophy of the reduced number of adipocytes. The first pattern consists of faintly acidophilic or albuminous small adipocytes that are retracted from the surrounding connective tissue of the septa. These changes are more prominent at the periphery of otherwise histologically normal fat lobules, suggesting that this is an early alteration of the lipoatrophic process. The general configuration of the fat lobule and the smallness of the adipocytes resemble those features of embryonic fat. Inflammatory cells are sparse and blood vessels appear prominent, congestive, and dilated. The second histopathologic pattern seen in lesions of lipoatrophy secondary to subcutaneous injections of corticosteroids is characterized by small atrophic fat cells surrounded by a prominent vasculature (Fig 19) . The smallness of the fat lobule and adipocytes, the relative absence of inflammation, and the proliferation of small blood vessels give an angiomatous appearance to the fat lobule.
In fully developed lesions of lipodystrophy there is an absence of subcutaneous fat with deposition of new collagen and with no evidence of inflammation. However, some authors have described an early inflammatory stage in lesions of lipodystrophy, with lymphocytes [311] [312] [313] and vascular involvement 284, 328 in the fat lobule. Recently, two histopathologic variants of lipodystrophy have been proposed. 329 In the first type, there are prominent involutional changes in the fat lobule, with small adipocytes and intervening hyaline or myxoid conadipocytes in the form of anucleated fat cells (Fig 18) are usually seen. 274 The process seems to be related to trauma, rapid vascular insufficiency, and subsequent fibrous capsule formation. As in other forms of residual lobular panniculitis, membranocystic or lipomembranous changes have been also described in lesions of mobile encapsulated lipoma. 276 At first glance, mobile encapsulated lipoma closely resembles lipoma, but close scrutiny reveals the absence of nuclei in well-preserved but necrotic adipocytes at the periphery of the lesion. 274 
Lipoatrophy
Atrophy of the subcutaneous fat may result from two different processes from a pathogenic point of view: lipoatrophy and lipodystrophy. Lipoatrophy refers specifically to a loss of subcutaneous fat due to a previous inflammatory process involving the subcutis. In contrast, lipodystrophy means an absence of subcutaneous fat with no evidence of inflammation. Lipodystrophy may be congenital or acquired and clinical variants include total, partial, and localized forms of lipodystrophy. 127, 277 It has been suggested that the so-called lipedema, characterized by the abnormal deposition of subcutaneous fat in the legs associated with edema, is a type of lipodystrophy. 278 Localized lipoatrophy has received different names according to its clinical appearance and location, including annular lipoatrophy, 279 abdominal lipoatrophy, 280 semicircular lipoatrophy, 281 and postinjection localized lipoatrophy. 282, 283 Lesions of localized lipoatrophy have been described as residual lesions of different types of panniculitis, 127, [284] [285] [286] [287] as well as at the points of injection of different drugs including antibiotics, 288 corticosteroids, 283, [288] [289] [290] [291] insulin, [292] [293] [294] [295] [296] vasopressin, 297 and human growth hormone. 298 Localized lipoatrophy secondary to pressure and compression by tight-fitting clothes has been described near the ankles, 299-301 on the thighs, 268, 281, 302 over the sacrum, 303 on abdominal skin, 280, [304] [305] [306] [307] [308] and on the extremities. 309, 310 In contrast, fully developed lesions of lipodystrophy show total absence of subcutaneous tissue with no evidence of inflammation, although some authors have postulated an early inflammatory stage in lipodystrophy lesions. [311] [312] [313] Total lipodystrophy consists of a complete congenital or acquired loss of subcutaneous tissue involving all body surfaces. Acquired total lipodystrophy is usually associated with hepatomegaly, hyperglycemia, hyperlipemia, hypermetabolism, and other endocrinologic and metabolic disorders. 127 Partial lipodystrophy usually begins on the face and is manifested by a symmetric loss of facial fat with or without atrophy of the subcutaneous fat of the arms and upper trunk. This nective tissue and proliferation of small blood vessels. The second type is the inflammatory type because lymphocytes, foamy histiocytes, and plasma cells appear within the small fat lobules with normal-appearing adipocytes and vasculature. Usually, cases of lipodystrophy with the second histopathologic pattern show multiple areas of localized lipodystrophy and direct immunofluorescence studies demonstrate immunoreactants in the blood vessel walls or in the basement membrane zone of the dermoepidermal junction. It is uncertain, however, whether or not these two patterns represent two different stages of a single process.
Treatment of localized lipoatrophy secondary to lesions of panniculitis is disappointing. Some improvement has been reported with oral and topical corticosteroids, 277 but it is questionable whether the effect is due to corticosteroids or to spontaneous improvement of the lesions with time. In some cases in which residual lipoatrophy led to important cosmetic deformity, improvement was achieved with reconstructive surgery. 285 Lipodystrophy also shows poor response to treatment. In localized forms, the lesions tend to recede over time, restoring some of the lost subcutaneous tissue.
Subcutaneous fat necrosis of the newborn
Subcutaneous fat necrosis of the newborn is a rare variant of lobular panniculitis that appears in newborns during the first days of life. 330, 331 Clinically, the lesions consist of indurated plaques or subcutaneous nodules with a predilection for the buttocks (Fig 20) , shoulders, cheeks, and thighs. [332] [333] [334] Often, infants affected by subcutaneous fat necrosis of the newborn have hypercalcemia of unknown significance. [335] [336] [337] [338] [339] [340] [341] [342] [343] [344] [345] Other etiologic factors that have been postulated in relationship with subcutaneous fat necrosis of the newborn include obstetric trauma 330, 331 and induced hypothermia for cardiac surgery. [346] [347] [348] Rare examples of subcutaneous fat necrosis of the newborn have been described after prostaglandin E administration, 344 in newborn infants with brown fat deficiency, 349 in infants with serum abnormalities of lipids and lipoproteins, 350 in newborns from mothers who used cocaine during pregnancy, 351 as a consequence of the intrapartum administration of calcium channel blockers, 352 and in association with thrombocytopenia. 353 The newborn has a relatively large body surface in comparison with weight and a greater ratio of saturated to unsaturated fatty acids than in adult fat, and these
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with a dense inflammatory infiltrate composed of lymphocytes, histiocytes, lipophages, multinucleated giant cells, and sometimes eosinophils interspersed among the adipocytes of the fat lobule. Many adipocytes are replaced by cells with finely eosinophilic granular cytoplasm that contain narrow needle-shaped clefts radially arranged (Fig 21) . These needle-shaped clefts represent crystals of triglycerides of the adipocytes. Some of these clefts may also be seen within the cytoplasm of multinucleated giant cells. 330, [357] [358] [359] The needle-shaped crystals in radial fashion within the cytoplasm of adipocytes and histiocytes are quite characteristic of subcutaneous fat necrosis of the newborn. They are not exclusive, however, because they have also been described in lesions of sclerema neonatorum and poststeroid panniculitis. Furthermore, in some cases of stereotypical examples of subcutaneous fat necrosis of the newborn, serial sections through the block did not demonstrate these clefts. 346 In late-stage lesions there is septal fibrosis and areas of calcification may appear within the fat lobule. Histopathologic differential diagnosis with lesions of sclerema neonatorum is straightforward because lesions of subcutaneous fat necrosis of the newborn show a dense inflammatory infiltrate of histiocytes and lymphocytes in the fat lobules. In lesions of sclerema neonatorum, the inflammatory infiltrate is characteristically lacking. 360 In contrast to sclerema neonatorum, infants with subcutaneous fat necrosis of the newborn have an excellent prognosis and the subcutaneous plaques and nodules spontaneously regress in a few days with no sequelae. Recently, etidronate, a diphosphonate, has been proposed as effective treatment for the associated hypercalcemia that frequently two factors favor the release of hydrolases that induce breakdown of unsaturated fatty acids caused by minor trauma. 330 Usually, cutaneous lesions of subcutaneous fat necrosis of the newborn develop during the first days of life, although cases with congenital and ulcerated lesions that were already present at delivery have also been described. 354 In an example of subcutaneous fat necrosis of the newborn, the cutaneous lesions appeared simultaneously with an episode of acute pancreatitis. 355 There is a report describing lesions of sclerema neonatorum and subcutaneous fat necrosis of the newborn in the same patient, 356 but usually these two variants of panniculitis of the newborn appear in infants with completely different clinical situations.
Histopathologically, most of the cases of subcutaneous fat necrosis of the newborn show characteristic findings. They consist of a mostly lobular panniculitis, appears in infants with subcutaneous fat necrosis of the newborn. 361
Poststeroid panniculitis
Poststeroid panniculitis is another rare variant of mostly lobular panniculitis that has been reported in children who were receiving high doses of systemic corticosteroids and in whom the doses were decreased quickly or steroid therapy was suddenly withdrawn. The reasons why these infants received high doses of systemic corticosteroids were variable, including rheumatic fever, leukemia, nephrotic syndrome, and cerebral edema. [362] [363] [364] [365] [366] [367] [368] [369] [370] Clinically, cutaneous lesions of poststeroid panniculitis consist of erythematous subcutaneous nodules that appear 1 to 10 days after cessation of high doses of systemic corticosteroids. Because the lesions develop mostly in those areas in which steroids induced the greatest accumulation of fat, subcutaneous nodules of poststeroid panniculitis appear mostly on the cheeks.
Histopathologically, lesions of poststeroid panniculitis show features similar to those of subcutaneous fat necrosis of the newborn. They consist of a mostly lobular panniculitis with an inflammatory infiltrate of foamy histiocytes and lymphocytes involving the fat lobules. Often, narrow strands of needle-shaped clefts are evident within the cytoplasm of some histiocytes, 370 although usually they are not as numerous as in subcutaneous fat necrosis of the newborn.
Lesions of poststeroid panniculitis gradually resolve during some weeks with no long-standing complications, except when ulceration occurs, leaving atrophic scars on the cheeks of the infant. If the diagnosis is established in early stages, readministration of high doses of systemic corticosteroid is indicated and then a slower and gradual decrease of the dose should be programmed.
Gout panniculitis
Patients with hyperuricemia may show urate crystal deposition in the fat lobule of the subcutis. As in tophus, urate crystals causing lobular panniculitis show a needle-like shape, have a tendency to form sheaves, and are doubly refractile under polarized light. Surrounding the urate crystals of the fat lobule is a granulomatous reaction with macrophages and many multinucleated giant cells. 371, 372 Crystal-storing histiocytosis
Crystal-storing histiocytosis is a rare disease in which aggregations of histiocytes containing crystalline deposits of immunoglobulins are seen in the subcutaneous fat. Crystal-storing histiocytosis appearing as a lobular panniculitis has been described in a patient with lymphoblastic lymphoma. 373 
Cytophagic histiocytic panniculitis
Two different processes are included under the term cytophagic histiocytic panniculitis; one is an authentic panniculitis, namely cytophagic histiocytic panniculitis, whereas the other one is a lymphoma with clinical appearance of panniculitis. The preferred term for the latter is subcutaneous "panniculitic" lymphoma. This is a high-grade aggressive lymphoma, nearly always with cytotoxic T-cell immunophenotype. 374 These two processes differ from the etiologic, clinical, histopathologic, and biologic behavioral aspects.
Cytophagic histiocytic panniculitis was first described as a distinct entity by Winkelmann and Bowie 375 in 1980. They proposed the following histopathologic criteria: a mostly lobular panniculitis with inflammatory infiltrate in the fat lobules composed of histiocytes and mature T lymphocytes, and with cytophagocytosis that results from macrophages that contain intact or fragmented erythrocytes, leukocytes, or lymphocytes within their cytoplasm, which produce the so-called "bean-bag" cells. In our review of the literature, we have found approximately 40 well-documented cases of cytophagic histiocytic panniculitis. An additional case considered to be sinus histiocytosis and massive lymphadenopathy (Rosai-Dorfman disease) showed lesions of lobular panniculitis with cytophagocytosis on the lower extremities and most likely represents an additional example of cytophagic histiocytic panniculitis. 405 Patients with cytophagic histiocytic panniculitis have a prolonged clinical course of the disease that lasts years and usually ends in a terminal state characterized by fever, hepatosplenomegaly, and pancytopenia secondary to hemocytophagocytosis involving the bone marrow. * However, there are also well-documented examples of cytophagic histiocytic panniculitis with a benign clinical behavior, even after a long follow-up period ranging from 7 months to 28 years. † Genotypic studies on the lymphoid cells involving the subcutaneous fat lobule did not demonstrate monoclonality in either early disease or in the terminal phase, 374 and no evidence of latent or active Epstein-Barr virus (EBV) infection as determined by in situ hybridization or serologic studies has been found in these cases. 374 Most of the patients with cytophagic histiocytic panniculitis show favorable response to immunosuppressive therapy with prednisone 389, 391, 395, 404 or cyclosporine. 388, 395, 397, 401 lesions with the clinical appearance of panniculitis (Fig 22) . Histopathologically, neoplastic lymphocytes involving the fat lobule show marked atypia, with large and hyperchromatic nuclei, karyorrhexis, and frequent atypical mitotic figures. Often atypical lymphocytes form a ring surrounding necrotic adipocytes (Fig 23) . There are also histiocytes showing cytophagocytosis that involve not only the subcutaneous fat, but also the bone marrow. Most of the patients with subcutaneous "panniculitic" lymphoma have a short clinical course with early death despite aggressive treatment with chemotherapy or radiotherapy, or both. Approximately 40 cases of subcutaneous "panniculitic" lymphoma have been described in the literature. 374, Immunohistochemical studies have demonstrated that atypical lymphoid cells have a cytotoxic T-cell phenotype. Most of the neoplastic lymphocytes express CD3, CD8, and cytotoxic granular proteins (TIA-1 and perforin) and lack expression of CD4. 409, 411, [417] [418] [419] [420] In rare instances, subcutaneous "panniculitic" lymphoma showing a Bcell immunophenotype of the neoplastic lymphocytes has been described. [427] [428] [429] [430] All but one case 416 of subcutaneous "panniculitic" lymphoma in which evidence of latent or active EBV infection has been investigated by serology, in situ hybridization, or PCR techniques yielded positive results. 374, 410, 422, 423, 427 Those cases of subcutaneous "panniculitic" lymphoma in which genotypic studies have been performed showed monoclonality of the atypical lymphocytes involving the fat lobule. 409, 410, [413] [414] [415] [416] 422 In summary, cytophagic histiocytic panniculitis and subcutaneous "panniculitic" lymphoma are two
In contrast, subcutaneous "panniculitic" lymphoma is not a panniculitis, but a malignant neoplastic proliferation of T lymphocytes that involves the subcutaneous fat lobules, resulting in cutaneous different pathologic processes, that is, the former is a lobular panniculitis and the latter is a malignant lymphoma. These two different diseases have in common a histopathologic finding, namely, the presence of cytophagocytosis in the subcutaneous fat that may also extend to the bone marrow. Patients with cytophagic histiocytic panniculitis have no evidence of latent or active EBV infection and show a prolonged clinical course, whereas patients with subcutaneous "panniculitic" lymphoma have serologic and/or genotypic evidence of EBV infection and the lymphoproliferative process shows an aggressive biologic behavior with early death. The patients recently described by RuizMaldonado et al 431 with "edematous, scarring vasculitic panniculitis: a new multisystemic disease with malignant potential" probably represent examples of subcutaneous "panniculitic" lymphoma in children, and 3 of the 4 cases in which in situ hybridization investigation for EBV infection has been performed showed positive results. 432 
Postirradiation pseudosclerodermatous panniculitis
Winkelmann et al 433 recently described 4 cases of women with breast cancer that was treated by radical mastectomy and radiotherapy. These patients developed indurated erythematous plaques on the irradiated skin 1 to 6 months after radiotherapy. Histopathologic study showed hyalin collagen bundles in the dermis and subcutaneous septa and an inflammatory infiltrate of lymphocytes and plasma cells involving the fat lobules. In some areas, lipophagic granuloma was seen at the periphery of the fat lobule. The authors named these lesions "postirradiation pseudosclerodermatous panniculitis." (Table II) 
DISORDERS ERRONEOUSLY CONSIDERED AS SPECIFIC VARIANTS OF PANNICULITIS
Weber-Christian disease
Weber-Christian disease is the term that has been classically used to refer to cases of mostly lobular panniculitis without vasculitis and systemic manifestations including fever and involvement of visceral fat tissue. Additional terms such as idiopathic nodular panniculitis, nodular panniculitis, and relapsing febrile nonsuppurative nodular panniculitis have been used as synonyms for Weber-Christian disease. The first cases of Weber-Christian disease as a distinct entity were described at the end of the 19th century and the beginning of the 20th century, [434] [435] [436] and similar cases appeared in the literature shortly afterward. [437] [438] [439] [440] [441] [442] [443] [444] However, many cases originally considered as examples of Weber-Christian disease were later reclassified when other variants of lobular panniculitis, including erythema induratum of Bazin (nodular vasculitis), pancreatic panniculitis, and α 1 -antitrypsin deficiency panniculitis, were separated as specific diseases. Currently many cases of lobular panniculitis may be attributed to specific causes, and, although some textbooks of dermatology 445, 446 and dermatopathlogy 37, 447 still include a section dedicated to Weber-Christian disease, most authors believe that Weber-Christian disease should no longer be considered a distinctive entity. [445] [446] [447] An interesting recent report on this topic is that of White and Winkelmann, 448 who reviewed the clinical and histopathologic features of 30 cases of panniculitis previously diagnosed as Weber-Christian disease at the Mayo Clinic. A review of the biopsy specimens of these 30 patients led to the conclusion that 12 cases were actually examples of erythema nodosum, 6 cases corresponded to superficial thrombophlebitis, 5 cases were reclassified as factitial panniculitis, 3 cases were traumatic panniculitis, 1 case was cytophagic histiocytic panniculitis, 1 case turned out to be subcutaneous "panniculitic" lymphoma, and 1 case resulted from subcutaneous involvement by leukemia. The authors concluded that the term Weber-Christian disease should be abandoned as a diagnosis for cases of lobular panniculitis because now a more specific diagnosis may be rendered in most cases. We agree with them.
Rothmann-Makai disease
Rothmann-Makai disease was the term used in the past to describe cases of relapsing nodular panniculitis similar to that of Weber-Christian disease, but with no fever or other systemic manifestations. 449, 450 Rothmann-Makai disease is also an obsolete term that is no longer used.
Lipomembranous or membranocystic panniculitis
Lipomembranous panniculitis was first described by Nasu, Tukahara, and Terayama 451 in 1973 as "membranous lipodystrophy." The authors considered the process as a specific and hereditary form of lobular panniculitis associated with anomalies of the long bones and neuropsychiatric manifestations.
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J AM ACAD DERMATOL VOLUME 45, NUMBER 3 266 panniculitis associated with dermatomyositis, 142, 456 subcutaneous "panniculitic" lymphoma, 457 septal 458 and lobular 459 panniculitis associated with Behçet's syndrome, arterial ischemia 460 and venous insufficiency 63, 65, 66, 461 of the lower extremities, and diabetic microangiopathy. 462, 463 Some authors distinguish between a primary lipomembranous panniculitis, when only the cystic structures are seen in the fat lobules, and secondary lipomembranous panniculitis when additional histopathologic features of a more specific variant of lobular panniculitis are present. 276, 453, 454 Probably, those cases considered to be primary lipomembranous panniculitis represent late-stage lesions of different types of lobular panniculitis and therefore are also examples of secondary lipomembranous panniculitis in which no other more specific histopathologic findings may be identified. In our opinion, the so-called lipomembranous or membranocystic panniculitis is a histopathologic pattern, but not a specific variant of panniculitis.
Eosinophilic panniculitis
Eosinophilic panniculitis is the term used to refer to those cases of septal or lobular panniculitis in However, cases with identical histopathologic findings were described shortly afterwards in late-stage lesions of several variants of lobular panniculitis; thus the term lipomembranous or membranocystic fat necrosis was proposed to refer these histopathologic features in different types of panniculitis. These findings consist of cystic spaces in the fat lobule that result from necrosis of the adipocytes. The cystic spaces are lined with a homogeneous eosinophilic membrane with convoluted projections into the cystic cavity (Fig 24) . These intracystic papillary projections stain brightly with periodic acid-Schiff and Sudan black and are resistant to diastase. [452] [453] [454] A case of lipomembranous fat necrosis showing myospherulosis, which consists of small bag structures containing tingible bodies that represent degenerated erythrocytes by lipids from adipocytes, has been recently described. 455 Lipomembranous fat necrosis seems to be especially frequent in late-stage lesions of sclerosing panniculitis, 63 although identical histopathologic findings have also been described in lesions of neutrophilic lobular panniculitis associated with rheumatoid arthritis, 10 erythema nodosum, 135 deep morphea, 452 lupus panniculitis, 134 traumatic panni- 
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which eosinophils predominate in the inflammatory infiltrate. Eosinophilic panniculitis is also a histopathologic pattern rather than a distinct entity. It has been described in several types of panniculitis and other inflammatory disorders involving the skin, including erythema nodosum, deep insect bites, narcotic dependency with injection granuloma, asthma, atopic dermatitis, psychiatric diseases, thyroid diseases, parotitis, glomerulonephritis, sarcoidosis, bacterial infections, infestation with the parasites Gnathostoma and Toxocara canis, leukocytoclastic vasculitis, systemic vasculitis, Well's syndrome, lupus panniculitis, deep morphea, Sjögren's syndrome, Tor B-cell lymphoma, leukemia, and solid neoplasms. 133, [464] [465] [466] [467] [468] [469] [470] This wide spectrum of disparate disorders indicates that eosinophilic panniculitis is a nonspecific reactive process, and the presence of eosinophils in the subcutaneous fat should be followed by pertinent clinical and laboratory investigations to rule out an associated systemic process. 468 Many colleagues contributed clinical photographs, histopathologic slides, or other material for this review. We are grateful to the following clinicians and pathologists: A. 27. Each of the following statements is true for subcutaneous fat necrosis of the newborn except a. it has been described after hypothermia for cardiac surgery b. it has been described after obstetric trauma c. it has been described as being associated with thrombocytopenia d. it has been described in infants with cystic fibrosis of the pancreas e. it has been described as a consequence of intrapartum administration of calcium channel blockers 
